Okada Y - Search Results

1

Decision analysis for treatment of early stage prostate cancer.

Yoshimura N, Takami N, Ogawa O, Kakehi Y, Okada Y, Fukui T, Yoshida O. Yoshimura N, et al. Among authors: okada y. Jpn J Cancer Res. 1998 Jun;89(6):681-9. doi: 10.1111/j.1349-7006.1998.tb03271.x. Jpn J Cancer Res. 1998. PMID: 9703367 Free PMC article.

2

Immunocytochemical detection of p53 in cultures of exfoliated cells from urine of patients with urothelial cancers.

Okuno H, Kakehi Y, Ogawa O, Yamada H, Ozdemir E, Okada Y, Yoshida O. Okuno H, et al. Among authors: okada y. Jpn J Cancer Res. 1996 Jul;87(7):718-23. doi: 10.1111/j.1349-7006.1996.tb00283.x. Jpn J Cancer Res. 1996. PMID: 8698621 Free PMC article.

3

Concomitant presence of p16/cyclin-dependent kinase 4 and cyclin D/cyclin-dependent kinase 4 complexes in LNCaP prostatic cancer cell line.

Itoh N, Kakehi Y, Akao T, Kinoshita H, Okada Y, Yoshida O. Itoh N, et al. Among authors: okada y. Jpn J Cancer Res. 1997 Mar;88(3):229-33. doi: 10.1111/j.1349-7006.1997.tb00371.x. Jpn J Cancer Res. 1997. PMID: 9140105 Free PMC article.

4

[Prognostic factors of prostatic cancer].

Okada Y, Shichiri Y, Ogawa O, Yoshida O. Okada Y, et al. Gan To Kagaku Ryoho. 1995 Nov;22(13):1999-2005. Gan To Kagaku Ryoho. 1995. PMID: 7487134 Review. Japanese.

5

[Human prostatic tissue specific antigens: a model for the research of monoclonal antibodies against unknown antigens].

Yoshiki T, Okada Y, Tomoyoshi T, Ueda M, Ogawa O, Yoshida O. Yoshiki T, et al. Among authors: okada y. Hinyokika Kiyo. 1993 Mar;39(3):213-9. Hinyokika Kiyo. 1993. PMID: 7685139 Free article. Japanese.

6

Serum granulocyte colony-stimulating factor levels in patients with urinary bladder tumour and various urological malignancies.

Mizutani Y, Okada Y, Terachi T, Kakehi Y, Yoshida O. Mizutani Y, et al. Among authors: okada y. Br J Urol. 1995 Nov;76(5):580-6. doi: 10.1111/j.1464-410x.1995.tb07782.x. Br J Urol. 1995. PMID: 8535676

7

HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma.

Ozdemir E, Kakehi Y, Nakamura E, Kinoshita H, Terachi T, Okada Y, Yoshida O. Ozdemir E, et al. Among authors: okada y. Cancer Res. 1997 Feb 15;57(4):742-6. Cancer Res. 1997. PMID: 9044854

8

Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity.

Mizutani Y, Okada Y, Yoshida O, Fukumoto M, Bonavida B. Mizutani Y, et al. Among authors: okada y. Cancer. 1997 Mar 15;79(6):1180-9. doi: 10.1002/(sici)1097-0142(19970315)79:6<1180::aid-cncr17>3.0.co;2-w. Cancer. 1997. PMID: 9070496

9

Expression of platelet-derived endothelial cell growth factor in bladder carcinoma.

Mizutani Y, Okada Y, Yoshida O. Mizutani Y, et al. Among authors: okada y. Cancer. 1997 Mar 15;79(6):1190-4. Cancer. 1997. PMID: 9070497

10

High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma.

Ozdemir E, Kakehi Y, Mishina M, Ogawa O, Okada Y, Ozdemir D, Yoshida O. Ozdemir E, et al. Among authors: okada y. Br J Cancer. 1997;76(10):1348-52. doi: 10.1038/bjc.1997.559. Br J Cancer. 1997. PMID: 9374382 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,259 results

Search Page

Filters